PTSM: Pharmaceutical Technology Sourcing and Management, Nov 9, 2011 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
PTSM: Pharmaceutical Technology Sourcing and Management, Nov 9, 2011
Manufacturing
Pfizer Outlines Its Supply Strategy
By Patricia Van Arnum
John Kelly, vice-president of strategy and transitioning sites for Pfizer Global Supply, discusses the company's manufacturing and supply strategy and network.
Global Feature
Contract Manufacturers and Ingredient Suppliers Assemble at CPhI Worldwide.
By Patricia Van Arnum
A roundup of news from fine-chemical suppliers, CDMOs, and CMOs from this year's installment of CPhI Worldwide.
APIs
Technical Perspectives from CPhI Worldwide
By Patricia Van Arnum
Pharmaceutical Technology's podcast series from CPhI.
Outsourcing
Preparing for the Last War
By Jim Miller
CROs that have made big acquisitions could be outmaneuvered by evolving sourcing models.
CSR and Sustainability Forum
Energy Conservation in Pharmaceutical Manufacturing
By L. Shamkishore , K. Manmadha Reddy , A. Pathy
The authors discuss opportunities for energy efficiency in pharmaceutical manufacturing.
Pharma Companies Focus on Advancing Women
By Patricia Van Arnum
Pharmaceutical companies join international efforts to reduce maternal and child mortality in the developing world.
CSR and Sustainability in the News
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other private and public organizations.

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here